We're another step closer to reducing the need for round-the-clock insulin injections to manage diabetes after a new study showed how insulin-producing cells could be regenerated in the pancreas.
Eh… it might. Harvoni and its relatives are a cure for HepC. They charge about a lifetime’s worth of liver treatment for a 3 month supply after which you’re most likely cured. Over here one course of Harvoni is worth over 110 average monthly supplies of Humira (a rather expensive biological blockbuster RA/Crohn’s drug). Insulin costs 5-10 times less depending on the user… I’m comparing apples to orange but you probably get the idea. Chronic illness is profitable but curing it yields a higher margin as your patient will likely survive the full course.
If/when it hits the market the pricetag would be about a lifetime’s+ supply of insulin probably.
This drug will never come out to market.
It might in European markets. Lifelong illness isn’t a money maker here. And if it’s available here it might become available in Murcia.
Eh… it might. Harvoni and its relatives are a cure for HepC. They charge about a lifetime’s worth of liver treatment for a 3 month supply after which you’re most likely cured. Over here one course of Harvoni is worth over 110 average monthly supplies of Humira (a rather expensive biological blockbuster RA/Crohn’s drug). Insulin costs 5-10 times less depending on the user… I’m comparing apples to orange but you probably get the idea. Chronic illness is profitable but curing it yields a higher margin as your patient will likely survive the full course.
If/when it hits the market the pricetag would be about a lifetime’s+ supply of insulin probably.
For sure. There is much money in a lifetime treatment. Little money in a permanent cure.